Bridgepoint Group plc’s planned purchase of Kayne Anderson Real Estate would add its fifth investment vertical; the target’s co-founder and CEO, Al Rabil, told CNBC financing strain was opening U.S. property opportunities.
Bridgepoint announced the agreement on June 29, 2026. It would pay $759 million in cash and issue about 189 million new shares, valuing the deal at an upfront enterprise value of roughly $1.393 billion. At the time, Kayne Anderson managed about $22 billion across real estate equity and debt strategies.
Bridgepoint said the purchase would add a real estate business to its platform, expand its U.S. reach and diversify the sources of recurring fee income. It listed Kayne Anderson’s specialties as medical office, seniors housing, student housing, multifamily housing and light industrial. Bridgepoint also said the manager would bring more than 115 institutional investor relationships, with limited overlap between the firms’ investor bases.
In the CNBC interview, Rabil said higher interest rates, rising capitalization rates and lower property valuations were weighing on real estate investors. He identified medical offices, small-bay industrial space and multifamily properties as areas with investment openings. For multifamily, he said some properties had sound underlying assets but strained capital structures as loans came due.
Cushman & Wakefield’s first-quarter report recorded 92.5% occupancy across medical outpatient buildings in the top 50 U.S. markets. Absorption reached 3.8 million square feet, 71% more than a year earlier.
Bridgepoint said its latest flagship equity fund, KAREP VII, secured $5.12 billion in commitments in May 2026, almost twice its predecessor’s commitments. The U.S. Federal Reserve held its federal funds target range at 3.75% to 4% on Oct. 28.
Bridgepoint’s Oct. 7 trading update said shareholder approval had been received on Oct. 1 and fund-investor approvals had also been secured. The company forecast that the transaction would lift earnings per share by a mid-single-digit percentage in 2027 and by more than 20% in 2028. Bridgepoint expects the deal to close Jan. 4, 2027.
